2021
DOI: 10.3390/nu13114050
|View full text |Cite
|
Sign up to set email alerts
|

AMPK Activity: A Primary Target for Diabetes Prevention with Therapeutic Phytochemicals

Abstract: Diabetes is a metabolic syndrome characterized by inadequate blood glucose control and is associated with reduced quality of life and various complications, significantly shortening life expectancy. Natural phytochemicals found in plants have been traditionally used as medicines for the prevention of chronic diseases including diabetes in East Asia since ancient times. Many of these phytochemicals have been characterized as having few side effects, and scientific research into the mechanisms of action responsi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
10
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(11 citation statements)
references
References 88 publications
(182 reference statements)
0
10
0
1
Order By: Relevance
“…In this research, we looked into the impacts of PSC-FEs on two principal pathways involved in insulin resistance, i.e., AMPK and AKT [ 4 , 19 ] and also on expression levels of INSR [ 20 ], GLUT1, and GLUT4 [ 21 ], as major regulators of glucose hemostasis.…”
Section: Discussionmentioning
confidence: 99%
“…In this research, we looked into the impacts of PSC-FEs on two principal pathways involved in insulin resistance, i.e., AMPK and AKT [ 4 , 19 ] and also on expression levels of INSR [ 20 ], GLUT1, and GLUT4 [ 21 ], as major regulators of glucose hemostasis.…”
Section: Discussionmentioning
confidence: 99%
“…Within this view, the hypolipidemic effect of AMPK can be attributed to its phosphorylation capabilities which result in the inhibition of lipogenesis and the stimulation of the oxidation of FAs by suppressing SREBP1, FA-synthesis genes, and ACC [ 66 ]. On the other hand, AMPK can reduce fasting glucose levels and enhance IR by stimulating peripheral glucose clearance and increasing the membranous translocation of GLUT2/4, and lowering membrane cholesterol [ 13 , 67 , 68 ]. Furthermore, the activation of AMPK by metformin, AICAR, and a-769662 has been shown to suppress hepatic gluconeogenesis and glucose production by reducing the expression and activation of key glucose-synthesis enzymes such as PEPCK and G6Pase activity in STZ-diabetic mice [ 66 , 69 ].…”
Section: Discussionmentioning
confidence: 99%
“…The adenosine monophosphate-activated protein kinase (AMPK) is the major energy sensor molecule in the majority of cells that can regulate substrate metabolism and stimulate ATP production and cell survival in response to high AMP or ADP/ATP ratio [ 12 ]. Even though AMPK is a novel regulator of cellular energy sensors, it functions as an important therapeutic target for obesity, metabolic disease, and DM by acting through defined metabolic pathways in the liver, adipose tissue, and muscles [ 13 ]. These mechanisms include inhibiting gluconeogenesis, stimulating glucose intake and FA oxidation, and suppressing lipogenesis [ 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…Diabetes mellitus (DM) is a chronic metabolic disorder chiefly characterized by hyperglycemia, and the incidence of DM is increasing worldwide [ 1 ]. Diabetic nephropathy (DN), the most common microvascular complication of DM, is primarily featured by albuminuria and progressive loss of kidney function [ 2 , 3 ].…”
Section: Introductionmentioning
confidence: 99%